Ari Daniel

Ari Daniel, a freelance science reporter who covered an innovative Pan-Africa HIV vaccine trial, shares field reporting from South Africa and Zanzibar. He describes lab work with long-term blood samples. He recounts a funding freeze that threatened the trial and how researchers regrouped with new, smaller funding. He follows the launch of the scaled-back trial and community reactions in Cape Town.

NPR reporter Ari Daniel brings insights from Cape Town’s HIV vaccine trial, highlighting the resilience of researchers despite setbacks from funding cuts. Virologist Penny Moore shares how long-term sample collections have fueled critical discoveries. Listeners will learn about the journey from halted trials to a scaled-down version backed by local funders, and hear about the quest for broadly neutralizing antibodies vital for vaccine development. The community's role is showcased as first vaccinations begin, showcasing hope and perseverance in the face of adversity.